Brought to you by 
ICBM Medical licenses biosensor technology from CWRU
06 Jul 2017
Executive Summary
ICBM Medical Inc. and Case Western Reserve University are allying to develop the university's rapid catalytic biomarker technology to develop low-cost, rapid, point-of-care patient screening and monitoring biosensors for various critical conditions, including cancer and neurological and metabolic disorders.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ICBM Medical licenses biosensor technology from CWRU
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice